IS5727A - Meðferðarsamsetningar af (valvísum) estrógen viðtakabeinum (SERM) og vaxtarhormónaseytum (GHS) til að meðhöndla veikleika beinagrindarvöðva - Google Patents

Meðferðarsamsetningar af (valvísum) estrógen viðtakabeinum (SERM) og vaxtarhormónaseytum (GHS) til að meðhöndla veikleika beinagrindarvöðva

Info

Publication number
IS5727A
IS5727A IS5727A IS5727A IS5727A IS 5727 A IS5727 A IS 5727A IS 5727 A IS5727 A IS 5727A IS 5727 A IS5727 A IS 5727A IS 5727 A IS5727 A IS 5727A
Authority
IS
Iceland
Prior art keywords
ghs
serm
selective
growth hormone
skeletal muscle
Prior art date
Application number
IS5727A
Other languages
English (en)
Inventor
Zhu Ke Hua
Li Mei
Codetta Pan Lydia
Duane Thompson David
Original Assignee
Pfizer Products Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Products Inc. filed Critical Pfizer Products Inc.
Publication of IS5727A publication Critical patent/IS5727A/is

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/08Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/08Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
IS5727A 1998-06-16 2000-11-24 Meðferðarsamsetningar af (valvísum) estrógen viðtakabeinum (SERM) og vaxtarhormónaseytum (GHS) til að meðhöndla veikleika beinagrindarvöðva IS5727A (is)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US8942498P 1998-06-16 1998-06-16
PCT/IB1999/000796 WO1999065488A1 (en) 1998-06-16 1999-05-03 Therapeutic combinations of (selective) estrogen receptor modulators (serm) and growth hormone secretagogues (ghs) for treating musculoskeletal frailty

Publications (1)

Publication Number Publication Date
IS5727A true IS5727A (is) 2000-11-24

Family

ID=22217565

Family Applications (1)

Application Number Title Priority Date Filing Date
IS5727A IS5727A (is) 1998-06-16 2000-11-24 Meðferðarsamsetningar af (valvísum) estrógen viðtakabeinum (SERM) og vaxtarhormónaseytum (GHS) til að meðhöndla veikleika beinagrindarvöðva

Country Status (29)

Country Link
EP (1) EP1085867A1 (is)
JP (1) JP2002518328A (is)
KR (1) KR20010052817A (is)
CN (1) CN1305378A (is)
AP (1) AP9901581A0 (is)
AR (1) AR018868A1 (is)
AU (1) AU3342099A (is)
BG (1) BG105128A (is)
BR (1) BR9911357A (is)
CA (1) CA2335112A1 (is)
CO (1) CO5070586A1 (is)
EA (1) EA200001189A1 (is)
GT (1) GT199900083A (is)
HR (1) HRP20000857A2 (is)
HU (1) HUP0102395A2 (is)
ID (1) ID26726A (is)
IL (1) IL139587A0 (is)
IS (1) IS5727A (is)
MA (1) MA26648A1 (is)
NO (1) NO20006381L (is)
OA (1) OA11569A (is)
PA (1) PA8472101A1 (is)
PE (1) PE20000633A1 (is)
PL (1) PL345064A1 (is)
SK (1) SK18902000A3 (is)
TN (1) TNSN99118A1 (is)
UY (1) UY25557A1 (is)
WO (1) WO1999065488A1 (is)
ZA (1) ZA993973B (is)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1004306A3 (en) * 1998-08-06 2000-06-07 Pfizer Products Inc. Estrogen agonists/antagonists
IL145106A0 (en) * 2000-08-30 2002-06-30 Pfizer Prod Inc Intermittent administration of a geowth hormone secretagogue
BR0113626A (pt) * 2000-08-30 2003-06-17 Pfizer Prod Inc Formulações de liberação sustentada para secretores de hormÈnio do crescimento
US7524866B2 (en) 2001-11-29 2009-04-28 Gtx, Inc. Prevention and treatment of androgen—deprivation induced osteoporosis
BR0214801A (pt) * 2001-11-29 2005-01-11 Gtx Inc Prevenção e tratamento de osteoporose induzida pela privação de andrógeno
US7476653B2 (en) 2003-06-18 2009-01-13 Tranzyme Pharma, Inc. Macrocyclic modulators of the ghrelin receptor
CU23558A1 (es) 2006-02-28 2010-07-20 Ct Ingenieria Genetica Biotech Compuestos análogos a los secretagogos peptidicos de la hormona de crecimiento
CN101657436A (zh) 2007-02-09 2010-02-24 特兰齐姆制药公司 大环生长素释放肽受体调节剂及其使用方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
UA51676C2 (uk) * 1995-11-02 2002-12-16 Пфайзер Інк. (-)цис-6(s)-феніл-5(r)[4-(2-піролідин-1-ілетокси)феніл]-5,6,7,8-тетрагідронафталін-2-ол d-тартрат, спосіб його одержання, спосіб лікування захворювань, що піддаються лікуванню агоністами естрогену, та фармацевтична композиція
TW432073B (en) * 1995-12-28 2001-05-01 Pfizer Pyrazolopyridine compounds
HN1996000101A (es) * 1996-02-28 1997-06-26 Inc Pfizer Terapia combinada para la osteoporosis

Also Published As

Publication number Publication date
ID26726A (id) 2001-02-01
KR20010052817A (ko) 2001-06-25
MA26648A1 (fr) 2004-12-20
WO1999065488A1 (en) 1999-12-23
BR9911357A (pt) 2001-03-13
EP1085867A1 (en) 2001-03-28
PE20000633A1 (es) 2000-07-26
AP9901581A0 (en) 1999-06-30
NO20006381D0 (no) 2000-12-14
BG105128A (en) 2001-11-30
TNSN99118A1 (fr) 2005-11-10
HRP20000857A2 (en) 2001-10-31
CN1305378A (zh) 2001-07-25
CO5070586A1 (es) 2001-08-28
IL139587A0 (en) 2002-02-10
NO20006381L (no) 2000-12-14
HUP0102395A2 (hu) 2001-11-28
ZA993973B (en) 2000-12-15
SK18902000A3 (sk) 2001-12-03
AR018868A1 (es) 2001-12-12
CA2335112A1 (en) 1999-12-23
PA8472101A1 (es) 2000-09-29
AU3342099A (en) 2000-01-05
PL345064A1 (en) 2001-11-19
EA200001189A1 (ru) 2001-06-25
OA11569A (en) 2004-07-01
GT199900083A (es) 2000-12-05
JP2002518328A (ja) 2002-06-25
UY25557A1 (es) 2001-01-31

Similar Documents

Publication Publication Date Title
IS5386A (is) Prótínblanda og ferli til að einangra prótínblöndu úr vöðvavef
DK0946190T3 (da) Fremgangsmåder og sammensætninger til stimulering af neuritvækst
EP1143987A4 (en) NATURAL COMPOSITION AND METHOD FOR TREATING SEXUAL DYSFUNCTIONS
ID23496A (id) Ekstrak tanaman untuk mengobati peningkatan resorpsi tulang
IS2390B (is) Aðferð við að fjarlægja vöðvakjöt af fiski og tæki til að framkvæma þá aðferð
EP1071841A4 (en) METHOD AND DEVICE FOR COUNTERFLOW TREATMENT OF SLUDGE
DK0898894T3 (da) Halvautomatisk indretning til udbening af griselår og fremgangsmåde til udbening af griselår under anvendelse af samme
IS5727A (is) Meðferðarsamsetningar af (valvísum) estrógen viðtakabeinum (SERM) og vaxtarhormónaseytum (GHS) til að meðhöndla veikleika beinagrindarvöðva
NO983641D0 (no) Fremgangsmåte til behandling og farmasöytisk preparat
EP1166904A4 (en) METHOD FOR THE DETOXIFICATION OF FLOORS
DK3497A (da) Formulering med vedvarende frigivelse af et animalsk væksthormon og fremgangsmåde til fremstilling deraf
IS5691A (is) Meðferðarsamsetningar af (valvísum) estrógen viðtaka beinum (SERM) og vaxtarhormóns seytum (GHS) til meðhöndlunar á veikleika í beinagrindarvöðva
GB2333290B (en) Method of water treatment using zeolite crystalloid coagulants
NO20011824D0 (no) Gjödningsblandinger med kontrollert frigjöring og fremgangsmåter for fremstilling derav
GB9913560D0 (en) Mixing apparatus and method of mixing
BR9508718A (pt) Estabelecimento e método para segregação de estrógeno tónico de ovário para regimes terapéuticos estendidos
NO20032969D0 (no) Fremgangsmåte for screening med hensyn på progesteronreseptorisoform-spesifikke ligander og med hensyn på vevs-selektiveprogesteronreseptorligander
PL336422A1 (en) Method of and apparatus for preparing asphalt mixes
EP1150669A4 (en) FORMULATIONS ON L-ARGININE BASE FOR DISEASE TREATMENT AND USE THEREOF
EP1009433A4 (en) THERAPEUTIC COMPOSITION AND TREATMENT METHOD
IS6428A (is) Aðferð og blanda til að meðhöndla sársauka
GB0010430D0 (en) Method and apparatus for non-manual installation of software,such as NT services
IL132652A0 (en) Use of 1-ar(al)yl-imidazolin-2-one for treating anxiety and stress conditions
DK1044592T3 (da) Fremgangsmåde og apparat til gödskning af jord
IS6427A (is) Efnasamband og aðferð til að meðhöndla sársauka